Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study.
| Author | |
|---|---|
| Abstract | :
Anticoagulant therapy for patients with sepsis is not recommended in the latest Surviving Sepsis Campaign guidelines, and non-anticoagulant therapy is the global standard treatment approach at present. We aimed at elucidating the effect of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation (DIC), as evidence on this topic has remained inconclusive. |
| Year of Publication | :
2018
|
| Journal | :
Thrombosis research
|
| Volume | :
163
|
| Number of Pages | :
22-29
|
| Date Published | :
2018
|
| ISSN Number | :
0049-3848
|
| DOI | :
10.1016/j.thromres.2017.12.022
|
| Short Title | :
Thromb Res
|
| Download citation |